​

​Interests in the utility of non-IgG antibodies for therapeutic purposes have been increasing in the last few years. Especially, IgMs, which are complex molecules consisting of 10 (pentameric IgM) or 12 (hexameric IgM) combining sites, have attracted much attention. As an expert in the development of therapeutic non-IgG antibodies, Creative Biolabs has been focusing on the disease therapy research, development, and applications of IgM antibodies for years. We now proudly present our IgM glycoengineering services to facilitate your therapeutic IgM antibody development.